Melanoma Clinician Resources

For decades, doctors and researchers have conducted clinical trials to further progress in the clinical implementation of tumor immunotherapy. Former President Jimmy Carter’s success with immunotherapy for advanced melanoma and Vice President Joe Biden’s Cancer Moonshot Initiative have brought this new treatment type, as well as cancer treatments in general, into the spotlight for the general public. As a result, health care professionals may experience a spike in inquiries about this new treatment.

Several immunotherapy agents are now available for melanoma. Although surgery often remains the first line of treatment, especially for early-stage melanomas, the U.S. Food and Drug Administration (FDA) is rapidly approving new immunotherapy medications for advanced melanoma.

Learn more about melanoma and how immunotherapy is changing the treatment landscape in the following pages:

Melanoma_Professional_Resource_Guide_cover.jpg

This content courtesy of Immunotherapy for the Treatment of Melanoma for Health Care Professionals.

Click to download the full PDF.

Discussions

  • This online meeting will connect you with all the recent research on how the tumor microenvironment influences cancer, and how its manipulation can provide potential means for immunotherapy. ...

  • Hi J. Gonzalo, Thanks for the registration details. I have confirmed your slot and I will keep you posted with the further updates. If any of your colleagues (Up to 10 people ...

  • Hi, I am interested to attend the webinar. Thanks in advance J. Gonzalo Ocejo-Vinyals, MD, PhD Immunogenetics and Histocompatibility Laboratory Santander, Spain ------------------------------ ...

  • Hi Dr. Satti , Thanks for the registration details. I have confirmed your slot and I will keep you posted with the further updates. If any of your colleagues (Up to 10 people ...

Resources

Jun 25, 2020 2:38 PM
New and fully validated tests need to be brought into clinical practice to improve the estimation of recurrence risk in patients with colon cancer. The aim of this study was to assess the analytical performances of the Immunoscore (IS) and show its contribution to prognosis prediction. The authors conclude ...
May 29, 2020 9:23 AM
A Message from the President Dear Colleagues, While the global coronavirus pandemic has held our attention since March, this edition of the President’s Message will focus on the greater mission that brings us all together. June is Cancer Immunotherapy Awareness Month™ , and so, first and most ...
May 27, 2020 4:09 PM
Immune checkpoint inhibitors (ICIs) can produce specific immune-related adverse events including pneumonitis. The impact of ICI therapy on the severity of acute coronavirus infection symptomatology warrants further exploration. The authors report the first case of a patient with melanoma with severe ...
May 27, 2020 4:04 PM
Immune-related colitis is a common, often serious complication of immune checkpoint inhibition (ICI). Although endoscopy is not strictly recommended for any grade of diarrhea/colitis, emerging evidence suggests that endoscopic evaluation may have important therapeutic implications. In this retrospective ...